IntroductionEvery morning, it takes time to clear phlegm for a while after waking up. Several times a year, yellow phlegm increases, a fever develops, and each time, antibiotics are prescribed. In a ...

From bringing your ID to the dentist to getting renovation support and revoking offensive licence plates, here are the latest ...

4D Molecular Therapeutics, Inc. is a late-stage biotechnology company advancing durable and disease-targeted therapeutics. The Company's lead product candidate 4D-150 is designed to be a backbone ...

Исследование MODULATE-CF демонстрирует, что тройная терапия возвращает функцию белка CFTR почти до нормы у детей, подтверждая ...

KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary ...

Airway stem cell transplantation achieves functional restoration and long-term engraftment in preclinical models, promising new opportunities for patients without gene-targeted options.

D Molecular Therapeutics has enrolled the first patients in a phase 3 trial of 4D-150 in diabetic macular edema, the company said Monday. The trial will enroll 514 treatment-naive patients ...

Alyftrek is a CFTR modulator, a type of medicine that acts directly on the faulty protein responsible for the disease. It ...

Die Mukoviszidose-Dreifachtherapie wirkt bei Kindern zwischen 2 und 11 Jahren deutlich stärker als bei Erwachsenen. Lesen Sie ...

Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the ...

Nonsense mutations are estimated to cause about 11 percent of inherited genetic disorders. Those disorders number in the ...